World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6877)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

1984

WORD

HTML

3496

Tables (1-2)

485

Sum=5995

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

222

Download

660

Sum=882

Apr 26, 2023 (publication date) through Nov 11, 2025

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	McCormack MD, Wahedna NA, Aldulaimi D, Hawker P. Emerging role of dual biologic therapy for the treatment of inflammatory bowel disease. World J Clin Cases 2023; 11(12): 2621-2630 [PMID: 37214562 DOI: 10.12998/wjcc.v11.i12.2621]
URL:	https://www.wjgnet.com/1007-9327/full/v11/i12/2621.htm

Number	Citing Articles
1	Michael Colwill, Samantha Baillie, Richard Pollok, Andrew Poullis. Using clinical cases to guide healthcare. World Journal of Clinical Cases 2024; 12(9): 1555-1559 doi: 10.12998/wjcc.v12.i9.1555 Abstract(873) \| Core Tip(720) \| Full Article(HTML)(1662) \| Full Article with Cover (PDF)-957K(96) \| Audio-409K(14) \| Peer-Review Report-170K(78) \| Answering Reviewers-81K(93) \| Full Article (PDF)-538K(128) \| Full Article (XML)-42K(86) \| Times Cited (0) \| Total Visits (6259) \| Open
2	Kate Lee, Violet Tu, Adam Faye. Optimal Management of Refractory Crohn’s Disease: Current Landscape and Future Direction. Clinical and Experimental Gastroenterology 2024; : 75 doi: 10.2147/CEG.S359376
3	Puo-Hsien Le, Chien-Ming Chen, Chia-Jung Kuo, Ming-Yao Su, Cheng-Tang Chiu, Yung-Kuan Tsou. Dual Biologic Therapy for Refractory Crohn's Disease With Perforation in a Patient Declining Surgical Intervention. ACG Case Reports Journal 2023; 10(11): e01203 doi: 10.14309/crj.0000000000001203
4	Mohammed Khalil Jnyah, Imane El Mezouar, Nessrine Akasbi, Taoufik Harzy. Pharmacological management of spondyloarthritis associated with inflammatory bowel disease: a systematic review of efficacy, safety, and emerging therapies. BMC Rheumatology 2025; 9(1) doi: 10.1186/s41927-025-00559-y
5	Javier P Gisbert, María Chaparro. Combination therapy with biologics and/or small molecules in inflammatory bowel disease: a comprehensive review. Journal of Crohn's and Colitis 2025; 19(9) doi: 10.1093/ecco-jcc/jjaf161
6	F. Carvajal, P. Núñez, R. Quera, G. Pizarro, L. Flores. Terapia combinada avanzada: inhibidores janus kinasas y anti-TNF en el tratamiento de pacientes con enfermedad inflamatoria intestinal. Revista de Gastroenterología de México 2025; doi: 10.1016/j.rgmx.2025.06.015
7	Fadi Hassan, Helana Jeries, Rula Daood, Mohammad Naffaa. Beyond Monotherapy: Exploring the Efficacy and Safety of Dual Biologic Strategies in Rheumatic Diseases. Biologics: Targets and Therapy 2025; : 665 doi: 10.2147/BTT.S565137
8	Arghya Samanta, Anshu Srivastava. Biologics in the management of pediatric inflammatory bowel disease: When and what to choose. World Journal of Clinical Pediatrics 2025; 14(1): 100938 doi: 10.5409/wjcp.v14.i1.100938 Abstract(460) \| Core Tip(475) \| Full Article(HTML)(5269) \| Full Article with Cover (PDF)-4150K(191) \| Audio-2330K(11) \| Peer-Review Report-222K(80) \| Answering Reviewers-63K(77) \| Full Article (PDF)-1397K(435) \| Full Article (XML)-427K(89) \| Times Cited (0) \| Total Visits (9746) \| Open
9	Christina M. Ray, Remo Panaccione, Christopher Ma. A practical guide to combination advanced therapy in inflammatory bowel disease. Current Opinion in Gastroenterology 2024; 40(4): 251 doi: 10.1097/MOG.0000000000001033
10	Mohamed Mahmoud Hafez, Ibrahim Halil Bahcecioglu, Mehmet Yalniz, Karim Abdelwahab Kouta, Ahmed Tawheed. Future of inflammatory bowel disease treatment: A review of novel treatments beyond guidelines. World Journal of Methodology 2025; 15(4): 107643 doi: 10.5662/wjm.v15.i4.107643 Abstract(230) \| Core Tip(210) \| Full Article(HTML)(5459) \| Full Article with Cover (PDF)-810K(110) \| Audio-186K(12) \| Peer-Review Report-329K(23) \| Answering Reviewers-307K(23) \| Full Article (PDF)-480K(169) \| Full Article (XML)-130K(26) \| Times Cited (0) \| Total Visits (6952) \| Open
11	Jessica R Allegretti, Liliana G Bordeianou, Oriana M Damas, Samuel Eisenstein, Ruby Greywoode, Phillip Minar, Siddharth Singh, Sabrina Harmon, Eugene Lisansky, Myisha Malone-King, Nicole S Litwin, Alandra Weaver, Caren A Heller, Alan C Moss, Jeremy Adler. Challenges in IBD Research 2024: Pragmatic Clinical Research. Inflammatory Bowel Diseases 2024; 30(Supplement_2): S55 doi: 10.1093/ibd/izae083
12	Giammarco Mocci, Antonio Tursi, Francesca Maria Onidi, Paolo Usai-Satta, Giovanni Mario Pes, Maria Pina Dore. Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms. Journal of Clinical Medicine 2024; 13(5): 1519 doi: 10.3390/jcm13051519
13	Hiu C. L. Sin, Craig Haifer. Faecal transplantation: the good, the bad and the ugly. Internal Medicine Journal 2025; 55(1): 35 doi: 10.1111/imj.16559